INTI Inhibitor Therapeutics, Inc.

Fundamentals / CIK 0001042418 / USD

Inhibitor Therapeutics, Inc. reported $247K in total assets and a net loss of $3.19M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open INTI in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$12.67M$6.34M$0-$7.57MFY 2016 Revenue: $0FY 2016 Net Income: -$7.00M2016FY 2017 Revenue: $0FY 2017 Net Income: -$5.10M2017FY 2018 Revenue: $0FY 2018 Net Income: -$4.55M2018FY 2019 Revenue: $0FY 2019 Net Income: -$2.73M2019FY 2020 Revenue: $0FY 2020 Net Income: -$1.06M2020FY 2021 Revenue: $0FY 2021 Net Income: -$299K2021FY 2022 Net Income: $12.11M2022FY 2023 Net Income: -$3.03M2023FY 2024 Net Income: -$3.34M2024FY 2025 Net Income: -$3.30M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- -- $0 $0 $0 $0 $0 $0
Research & Development $1.70M $1.76M $1.38M $6.2K $4.9K $185K $1.21M $2.63M $2.23M $2.64M
Total Operating Expenses $3.43M $3.66M $3.40M $658K $325K $1.06M $2.75M $4.56M $5.12M $7.02M
Operating Income -$3.43M -$3.66M -$3.40M -$658K -$325K -$1.06M -$2.75M -$4.56M -$5.12M -$7.02M
Interest Expense -- -- -- $23K $15K -- -- -- -- --
Income Before Tax -- -- -$3.03M $12.16M -$299K -- -- -- -- --
Income Tax Expense -- -- -- $55K $0 $0 $0 $0 $0 $0
Net Income -$3.30M -$3.34M -$3.03M $12.11M -$299K -$1.06M -$2.73M -$4.55M -$5.10M -$7.00M
Basic EPS -$0.02 -$0.02 -$0.02 $0.03 $0.00 $0.00 -$0.01 -$0.01 -$0.01 -$0.02
Diluted EPS -$0.02 -$0.02 -$0.02 $0.03 $0.00 $0.00 -$0.01 -$0.01 -$0.01 -$0.02
Basic Shares Outstanding 172.5M 172.3M 172.0M 366.2M 376.2M 371.9M 370.4M 369.8M 366.6M 288.8M
Diluted Shares Outstanding 172.5M 172.3M 172.0M 366.2M 376.2M 371.9M 370.4M 369.8M 366.6M 288.8M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $228K $224K $341K $757K $378K $326K $236K $888K
Total Operating Expenses $592K $619K $696K $1.32M $741K $696K $675K $1.48M
Operating Income -$592K -$619K -$696K -$1.32M -$741K -$696K -$675K -$1.48M
Net Income -$590K -$614K -$686K -$1.30M -$712K -$660K -$633K -$1.42M
Basic EPS $0.00 $0.00 $0.00 -- $0.00 $0.00 $0.00 --
Diluted EPS $0.00 $0.00 $0.00 -- $0.00 $0.00 $0.00 --
Basic Shares Outstanding 173.8M 173.3M 172.6M -- 172.6M 172.6M 172.3M --
Diluted Shares Outstanding 173.8M 173.3M 172.6M -- 172.6M 172.6M 172.3M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $2.38M $5.61M $8.84M $11.95M $31K $75K $804K $1.11M $344K $6.89M
Cash & Short-Term Investments $2.38M $5.61M $8.84M $11.95M $31K $75K $804K $1.11M $344K $6.89M
Total Current Assets $2.45M $5.69M $8.95M $11.98M $59K $107K $846K $1.15M $656K $7.20M
Other Non-Current Assets -- -- -- -- $0 $24K $54K $83K $112K $142K
Total Non-Current Assets $64K $0 $0 $0 $0 $24K $54K $83K $112K $142K
Total Assets $2.51M $5.69M $8.95M $11.98M $59K $132K $900K $1.23M $768K $7.34M
Accounts Payable $52K $16K $34K $145K $280K $269K $316K $385K $535K $298K
Other Current Liabilities -- -- -- -- $53K $25K $14K $216K $67K $10K
Total Current Liabilities $766K $710K $665K $679K $680K $425K $431K $701K $601K $308K
Long-Term Debt $37K -- -- -- -- -- -- -- -- --
Deferred Revenue (Non-Current) $3.00M $3.00M $3.00M $3.00M $3.00M $3.00M $3.00M $500K -- --
Total Non-Current Liabilities $3.04M $3.00M $3.00M $3.00M $3.00M $3.07M $3.00M $500K $0 $0
Total Liabilities $3.80M $3.71M $3.67M $3.68M $3.68M $3.49M $3.43M $1.20M $601K $308K
Total Debt (incl. Leases) $99K -- -- -- -- -- -- -- -- --
Common Stock $17K $17K $17K $17K $38K $37K $37K $37K $37K $35K
Retained Earnings -$55.42M -$52.12M -$48.78M -$45.75M -$57.67M -$57.17M -$55.91M -$52.98M -$48.27M -$43.17M
Total Stockholders' Equity -$1.29M $1.99M $5.28M $8.30M -$3.62M -$3.36M -$2.53M $32K $167K $7.03M
Total Equity -$1.29M $1.99M $5.28M $8.30M -$3.62M -$3.36M -$2.53M $32K $167K $7.03M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $146K $516K $1.29M $2.38M $2.98M $3.74M $4.32M $5.61M
Cash & Short-Term Investments $146K $516K $1.29M $2.38M $2.98M $3.74M $4.32M $5.61M
Total Current Assets $204K $587K $1.38M $2.45M $3.06M $3.83M $4.42M $5.69M
Total Non-Current Assets $43K $50K $57K $64K $71K $78K $84K $0
Total Assets $247K $637K $1.43M $2.51M $3.14M $3.91M $4.51M $5.69M
Accounts Payable $221K $139K $320K $52K $20K $106K $37K $16K
Total Current Liabilities $383K $175K $382K $766K $88K $140K $95K $710K
Long-Term Debt $14K $22K $29K $37K $44K $52K $58K --
Deferred Revenue (Non-Current) $3.00M $3.00M $3.00M $3.00M $3.00M $3.00M $3.00M $3.00M
Total Non-Current Liabilities $3.01M $3.02M $3.03M $3.04M $3.04M $3.05M $3.06M $3.00M
Total Liabilities $3.40M $3.20M $3.41M $3.80M $3.13M $3.19M $3.15M $3.71M
Total Debt (incl. Leases) $14K $22K $29K $99K $116K $130K $143K --
Common Stock $17K $17K $17K $17K $17K $17K $17K $17K
Retained Earnings -$57.31M -$56.72M -$56.11M -$55.42M -$54.12M -$53.41M -$52.75M -$52.12M
Total Stockholders' Equity -$3.15M -$2.56M -$1.98M -$1.29M $3.5K $716K $1.35M $1.99M
Total Equity -$3.15M -$2.56M -$1.98M -$1.29M $3.5K $716K $1.35M $1.99M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$3.30M -$3.34M -$3.03M $12.11M -$299K -$1.06M -$2.73M -$4.55M -$5.10M -$7.00M
Stock-Based Compensation $23K $40K $14K -- $38K $229K $270K $543K $1.87M $3.56M
Operating Cash Flow -$3.23M -$3.23M -$2.70M $11.74M -$220K -$825K -$2.71M -$3.71M -$2.91M -$3.76M
Common Stock Issued -- -- -- -- -- -- -- -- -- $2.66M
Dividends Paid -- -- -- -- -- $0 -$99K -- -- --
Financing Cash Flow -- -- -$411K $180K $176K $97K $2.40M $4.47M -$3.63M $10.04M
Net Change in Cash -$3.23M -$3.23M -$3.11M $11.92M -$44K -$729K -$305K $765K -$6.54M $6.28M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$590K -$614K -$686K -$1.30M -$712K -$660K -$633K -$1.42M
Stock-Based Compensation -- -- -- -- -- -- -- $0
Operating Cash Flow -$370K -$775K -$1.08M -$601K -$761K -$584K -$1.28M -$771K
Net Change in Cash -$370K -$775K -$1.08M -$601K -$761K -$584K -$1.28M -$771K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -- -168.2% -57.3% 145.9% -- -- -- -14065.2% -3062.6% -99.6%
Return on Assets (ROA) -131.4% -58.6% -33.8% 101.1% -508.0% -802.9% -303.7% -369.0% -664.2% -95.4%
Current Ratio 3.19x 8.02x 13.45x 17.64x 0.09x 0.25x 1.96x 1.64x 1.09x 23.36x
Quick Ratio 3.10x 7.90x 13.29x 17.61x 0.05x 0.18x 1.86x 1.58x 0.57x 22.35x
Net Income Growth (YoY) -- -- -125.0% -- -- -- -- -- -- --
EPS Growth (YoY) -- -- -166.7% -- -- -- -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -123.0% -- -- -- -- -- -- --
5Y Net Income / Share Growth -- -- -- -- -- -- -- -- -201.9% --
10Y Net Income / Share Growth -- -- -- +142.1% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -- -- -- -- -99241.7% -481.5% -243.1% -168.2%
Return on Assets (ROA) -1288.1% -519.1% -234.0% -131.4% -109.3% -88.2% -73.0% -58.6%
Current Ratio 0.53x 3.36x 3.60x 3.19x 35.00x 27.36x 46.68x 8.02x
Quick Ratio 0.38x 2.95x 3.38x 3.10x 34.01x 26.71x 45.63x 7.90x
Debt to Equity -- -- -- -- 33.54x 0.18x 0.11x --
Source: SEC EDGAR CompanyFacts (CIK 0001042418) · from September 30, 2012 Data through September 30, 2026 · synced Nov 21, 2026, 05:05 UTC · Open in terminal